MIH
NTGN

Meitav Investment House’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Meitav Investment House’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-639,465
Closed -$3M – 492
2019
Q2 		$3M Sell
639,465
-9,413
-1% -$52.7K 0.2% 69
2019
Q1 		$4.19M Hold
648,878
– – 0.24% 63
2018
Q4 		$3.26M Hold
648,878
– – 0.2% 72
2018
Q3 		$5.45M Buy
+648,878
New +$7.19M 0.27% 67

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meitav Investment House's NTGN Position: Q3 2019 in Review

Meitav Investment House sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 639,465 shares — an estimated $3M sold.

Meitav Investment House first reported a position in NTGN in Q3 2018 and held it in 4 quarters. The position peaked at $5.45M in Q3 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

  • Meitav Investment House reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Meitav Investment House sold 639,465 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $3M.
  • Meitav Investment House first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
  • Meitav Investment House's Neon Therapeutics, Inc. Common Stock position peaked at $5.45M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Meitav Investment House's 13F filing for Q3 2019, filed 14 Nov 2019.